- This event has passed.
Hormonal Contraception and HIV Risk: Understanding the ECHO Trial
March 11, 2019 @ 9:00 am - 1:00 pm UTC-5
A Family Planning Stakeholders Meeting
Monday, March 11, 2019
9:00 am – 1:00 pm
United Nations Foundation
1750 Pennsylvania Ave., 12th Floor
Washington, DC 20006
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label, randomized, clinical trial comparing three highly effective, reversible methods of contraception — the progestogen-only injectable depot-medroxyprogesterone acetate (DMPA), a levonorgestrel implant, and the non-hormonal copper intrauterine device — to evaluate whether there is any difference in the risk of acquiring HIV infection among users of these methods.
Results, expected in mid-2019, will help guide the implementation of safe, effective policies and services that will enable women at high risk of HIV to make fully informed choices about contraception and HIV prevention.
Join us to discuss the anticipated ECHO trial results, and help craft a plan to move forward as a global community. After the meeting, please stay for an informal lunch.
Space is limited. Please RSVP to hjohnson@familyplanning2020.org